Global Biopsy Forceps Market review

Biopsy Forceps Comprehensive Study by Type (Rigid Biopsy Forceps, Flexible Biopsy Forceps), Application (Hysteroscopy, Laparoscopy, Hysterectomy, Others), Distribution Channel (Offline, Online) Players and Region - Global Market Outlook to 2030

Biopsy Forceps Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Biopsy Forceps
Biopsy Forceps is referred to as an Olympus which offers a complete line of high-performing, disposable EndoJaw biopsy forceps. They are available in the sizes which will fit down to a 2.0 mm scope channel and are specially designed for easy positioning to the target biopsy site. A full line of reusable forceps is also been available to fit down to a 1.2 mm scope channel size. The market of the biopsy forceps is growing due to rising geriatric population also there is emergence of the cost effective solutions. But there are some of the aspects which can hamper the market, like reuse of Biopsy Forceps can cause the infection which may hinder the overall market

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR6.3%


Competition among existing players is due to the Industrial lighting market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Industrial lighting Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Analyst at AMA Research estimates that United States, Japanese and Chinese Players will contribute the maximum growth to Global Biopsy Forceps market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

OLYMPUS (Japan), Boston Scientific (United States), KARL STORZ (United States), Cook Medical (United States), Argon Medical (United States), ConMed (United States), Fujifilm (Japan), Cordis J&J (United States), Wilson (United States) and Alton (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Tiansong (China) and Jiuhong (China).

Segmentation Overview
AMA Research has segmented the market of Global Biopsy Forceps market by Type (Rigid Biopsy Forceps and Flexible Biopsy Forceps), Application (Hysteroscopy, Laparoscopy, Hysterectomy and Others) and Region.



On the basis of geography, the market of Biopsy Forceps has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Offline will boost the Biopsy Forceps market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Vacuum-assisted biopsy forceps offering minimal invasiveness and favorable reimbursement policies and Development in minimally invasive medical procedures that offers numerous advantages over traditional procedures

Market Growth Drivers:
Growing geriatric population and emergence of cost effective solution, Increasing healthcare expenditure and recent improvements in the healthcare infrastructure and Rising incidences of fatal cancer among patients

Challenges:
Reuse can cause infection and Substitute can capture the market

Restraints:
Higher cost of the products owing to constant upgrades

Opportunities:
The recent technological advancement coupled with development of the novel products & techniques such as advanced biopsy guidance systems and vacuum assisted guns are expected to provide platform for the sustained growth of biopsy forceps market in upcoming years

Market Leaders and their expansionary development strategies
In April 2018, Boston Scientific Corporation closes its acquisition of NxThera. The company developed the Rezūm system, a minimally invasive therapy (MIT) for patients with symptomatic benign prostatic hyperplasia (BPH). With the completion of the acquisition, NxThera will become part of the Boston Scientific Urology and Pelvic Health business
In June 2020, Cook Medical announced the commercial launch of two products for biliary duct procedures in the United States, the transluminal Biliary Biopsy Forceps Set (BBFS) and a new 40-cm delivery system line extension of the existing Zilver 635 biliary stent (ZIB) in the United States.


Key Target Audience
Biopsy Forceps Manufacturer, Sub component manufacturer, Channel partners, Industry association, Downstream vendors, Government and investment communities, Research organisation and associations and End user

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Rigid Biopsy Forceps
  • Flexible Biopsy Forceps
By Application
  • Hysteroscopy
  • Laparoscopy
  • Hysterectomy
  • Others
By Distribution Channel
  • Offline
  • Online

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing geriatric population and emergence of cost effective solution
      • 3.2.2. Increasing healthcare expenditure and recent improvements in the healthcare infrastructure
      • 3.2.3. Rising incidences of fatal cancer among patients
    • 3.3. Market Challenges
      • 3.3.1. Reuse can cause infection
      • 3.3.2. Substitute can capture the market
    • 3.4. Market Trends
      • 3.4.1. Vacuum-assisted biopsy forceps offering minimal invasiveness and favorable reimbursement policies
      • 3.4.2. Development in minimally invasive medical procedures that offers numerous advantages over traditional procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biopsy Forceps, by Type, Application, Distribution Channel and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Biopsy Forceps (Value)
      • 5.2.1. Global Biopsy Forceps by: Type (Value)
        • 5.2.1.1. Rigid Biopsy Forceps
        • 5.2.1.2. Flexible Biopsy Forceps
      • 5.2.2. Global Biopsy Forceps by: Application (Value)
        • 5.2.2.1. Hysteroscopy
        • 5.2.2.2. Laparoscopy
        • 5.2.2.3. Hysterectomy
        • 5.2.2.4. Others
      • 5.2.3. Global Biopsy Forceps by: Distribution Channel (Value)
        • 5.2.3.1. Offline
        • 5.2.3.2. Online
      • 5.2.4. Global Biopsy Forceps Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Biopsy Forceps: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. OLYMPUS (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. KARL STORZ (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cook Medical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Argon Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ConMed (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fujifilm (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cordis J&J (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Wilson (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Alton (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biopsy Forceps Sale, by Type, Application, Distribution Channel and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Biopsy Forceps (Value)
      • 7.2.1. Global Biopsy Forceps by: Type (Value)
        • 7.2.1.1. Rigid Biopsy Forceps
        • 7.2.1.2. Flexible Biopsy Forceps
      • 7.2.2. Global Biopsy Forceps by: Application (Value)
        • 7.2.2.1. Hysteroscopy
        • 7.2.2.2. Laparoscopy
        • 7.2.2.3. Hysterectomy
        • 7.2.2.4. Others
      • 7.2.3. Global Biopsy Forceps by: Distribution Channel (Value)
        • 7.2.3.1. Offline
        • 7.2.3.2. Online
      • 7.2.4. Global Biopsy Forceps Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biopsy Forceps: by Type(USD Million)
  • Table 2. Biopsy Forceps Rigid Biopsy Forceps , by Region USD Million (2018-2023)
  • Table 3. Biopsy Forceps Flexible Biopsy Forceps , by Region USD Million (2018-2023)
  • Table 4. Biopsy Forceps: by Application(USD Million)
  • Table 5. Biopsy Forceps Hysteroscopy , by Region USD Million (2018-2023)
  • Table 6. Biopsy Forceps Laparoscopy , by Region USD Million (2018-2023)
  • Table 7. Biopsy Forceps Hysterectomy , by Region USD Million (2018-2023)
  • Table 8. Biopsy Forceps Others , by Region USD Million (2018-2023)
  • Table 9. Biopsy Forceps: by Distribution Channel(USD Million)
  • Table 10. Biopsy Forceps Offline , by Region USD Million (2018-2023)
  • Table 11. Biopsy Forceps Online , by Region USD Million (2018-2023)
  • Table 12. South America Biopsy Forceps, by Country USD Million (2018-2023)
  • Table 13. South America Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 14. South America Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 15. South America Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 16. Brazil Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 17. Brazil Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 18. Brazil Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 19. Argentina Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 20. Argentina Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 21. Argentina Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 22. Rest of South America Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 24. Rest of South America Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 25. Asia Pacific Biopsy Forceps, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 28. Asia Pacific Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 29. China Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 30. China Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 31. China Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 32. Japan Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 33. Japan Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 34. Japan Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 35. India Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 36. India Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 37. India Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 38. South Korea Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 39. South Korea Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 40. South Korea Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 41. Taiwan Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 42. Taiwan Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 43. Taiwan Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 44. Australia Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 45. Australia Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 46. Australia Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 50. Europe Biopsy Forceps, by Country USD Million (2018-2023)
  • Table 51. Europe Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 52. Europe Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 53. Europe Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 54. Germany Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 55. Germany Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 56. Germany Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 57. France Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 58. France Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 59. France Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 60. Italy Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 61. Italy Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 62. Italy Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 63. United Kingdom Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 65. United Kingdom Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 66. Netherlands Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 67. Netherlands Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 68. Netherlands Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 69. Rest of Europe Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 71. Rest of Europe Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 72. MEA Biopsy Forceps, by Country USD Million (2018-2023)
  • Table 73. MEA Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 74. MEA Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 75. MEA Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 76. Middle East Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 77. Middle East Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 78. Middle East Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 79. Africa Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 80. Africa Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 81. Africa Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 82. North America Biopsy Forceps, by Country USD Million (2018-2023)
  • Table 83. North America Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 84. North America Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 85. North America Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 86. United States Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 87. United States Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 88. United States Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 89. Canada Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 90. Canada Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 91. Canada Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 92. Mexico Biopsy Forceps, by Type USD Million (2018-2023)
  • Table 93. Mexico Biopsy Forceps, by Application USD Million (2018-2023)
  • Table 94. Mexico Biopsy Forceps, by Distribution Channel USD Million (2018-2023)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Biopsy Forceps: by Type(USD Million)
  • Table 106. Biopsy Forceps Rigid Biopsy Forceps , by Region USD Million (2025-2030)
  • Table 107. Biopsy Forceps Flexible Biopsy Forceps , by Region USD Million (2025-2030)
  • Table 108. Biopsy Forceps: by Application(USD Million)
  • Table 109. Biopsy Forceps Hysteroscopy , by Region USD Million (2025-2030)
  • Table 110. Biopsy Forceps Laparoscopy , by Region USD Million (2025-2030)
  • Table 111. Biopsy Forceps Hysterectomy , by Region USD Million (2025-2030)
  • Table 112. Biopsy Forceps Others , by Region USD Million (2025-2030)
  • Table 113. Biopsy Forceps: by Distribution Channel(USD Million)
  • Table 114. Biopsy Forceps Offline , by Region USD Million (2025-2030)
  • Table 115. Biopsy Forceps Online , by Region USD Million (2025-2030)
  • Table 116. South America Biopsy Forceps, by Country USD Million (2025-2030)
  • Table 117. South America Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 118. South America Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 119. South America Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 120. Brazil Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 121. Brazil Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 122. Brazil Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 123. Argentina Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 124. Argentina Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 125. Argentina Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 126. Rest of South America Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 127. Rest of South America Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 128. Rest of South America Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 129. Asia Pacific Biopsy Forceps, by Country USD Million (2025-2030)
  • Table 130. Asia Pacific Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 131. Asia Pacific Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 132. Asia Pacific Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 133. China Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 134. China Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 135. China Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 136. Japan Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 137. Japan Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 138. Japan Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 139. India Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 140. India Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 141. India Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 142. South Korea Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 143. South Korea Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 144. South Korea Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 145. Taiwan Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 146. Taiwan Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 147. Taiwan Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 148. Australia Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 149. Australia Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 150. Australia Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 154. Europe Biopsy Forceps, by Country USD Million (2025-2030)
  • Table 155. Europe Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 156. Europe Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 157. Europe Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 158. Germany Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 159. Germany Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 160. Germany Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 161. France Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 162. France Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 163. France Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 164. Italy Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 165. Italy Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 166. Italy Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 167. United Kingdom Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 168. United Kingdom Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 169. United Kingdom Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 170. Netherlands Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 171. Netherlands Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 172. Netherlands Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 173. Rest of Europe Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 174. Rest of Europe Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 175. Rest of Europe Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 176. MEA Biopsy Forceps, by Country USD Million (2025-2030)
  • Table 177. MEA Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 178. MEA Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 179. MEA Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 180. Middle East Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 181. Middle East Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 182. Middle East Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 183. Africa Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 184. Africa Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 185. Africa Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 186. North America Biopsy Forceps, by Country USD Million (2025-2030)
  • Table 187. North America Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 188. North America Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 189. North America Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 190. United States Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 191. United States Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 192. United States Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 193. Canada Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 194. Canada Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 195. Canada Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 196. Mexico Biopsy Forceps, by Type USD Million (2025-2030)
  • Table 197. Mexico Biopsy Forceps, by Application USD Million (2025-2030)
  • Table 198. Mexico Biopsy Forceps, by Distribution Channel USD Million (2025-2030)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biopsy Forceps: by Type USD Million (2018-2023)
  • Figure 5. Global Biopsy Forceps: by Application USD Million (2018-2023)
  • Figure 6. Global Biopsy Forceps: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America Biopsy Forceps Share (%), by Country
  • Figure 8. Asia Pacific Biopsy Forceps Share (%), by Country
  • Figure 9. Europe Biopsy Forceps Share (%), by Country
  • Figure 10. MEA Biopsy Forceps Share (%), by Country
  • Figure 11. North America Biopsy Forceps Share (%), by Country
  • Figure 12. Global Biopsy Forceps share by Players 2023 (%)
  • Figure 13. Global Biopsy Forceps share by Players (Top 3) 2023(%)
  • Figure 14. Global Biopsy Forceps share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. OLYMPUS (Japan) Revenue, Net Income and Gross profit
  • Figure 17. OLYMPUS (Japan) Revenue: by Geography 2023
  • Figure 18. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 19. Boston Scientific (United States) Revenue: by Geography 2023
  • Figure 20. KARL STORZ (United States) Revenue, Net Income and Gross profit
  • Figure 21. KARL STORZ (United States) Revenue: by Geography 2023
  • Figure 22. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cook Medical (United States) Revenue: by Geography 2023
  • Figure 24. Argon Medical (United States) Revenue, Net Income and Gross profit
  • Figure 25. Argon Medical (United States) Revenue: by Geography 2023
  • Figure 26. ConMed (United States) Revenue, Net Income and Gross profit
  • Figure 27. ConMed (United States) Revenue: by Geography 2023
  • Figure 28. Fujifilm (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Fujifilm (Japan) Revenue: by Geography 2023
  • Figure 30. Cordis J&J (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cordis J&J (United States) Revenue: by Geography 2023
  • Figure 32. Wilson (United States) Revenue, Net Income and Gross profit
  • Figure 33. Wilson (United States) Revenue: by Geography 2023
  • Figure 34. Alton (China) Revenue, Net Income and Gross profit
  • Figure 35. Alton (China) Revenue: by Geography 2023
  • Figure 36. Global Biopsy Forceps: by Type USD Million (2025-2030)
  • Figure 37. Global Biopsy Forceps: by Application USD Million (2025-2030)
  • Figure 38. Global Biopsy Forceps: by Distribution Channel USD Million (2025-2030)
  • Figure 39. South America Biopsy Forceps Share (%), by Country
  • Figure 40. Asia Pacific Biopsy Forceps Share (%), by Country
  • Figure 41. Europe Biopsy Forceps Share (%), by Country
  • Figure 42. MEA Biopsy Forceps Share (%), by Country
  • Figure 43. North America Biopsy Forceps Share (%), by Country
List of companies from research coverage that are profiled in the study
  • OLYMPUS (Japan)
  • Boston Scientific (United States)
  • KARL STORZ (United States)
  • Cook Medical (United States)
  • Argon Medical (United States)
  • ConMed (United States)
  • Fujifilm (Japan)
  • Cordis J&J (United States)
  • Wilson (United States)
  • Alton (China)
Additional players considered in the study are as follows:
Tiansong (China) , Jiuhong (China)
Select User Access Type

Key Highlights of Report


Mar 2024 227 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biopsy Forceps Market review Quantitative research analysis
Global Biopsy Forceps Market review Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as OLYMPUS (Japan), Boston Scientific (United States), KARL STORZ (United States), Cook Medical (United States), Argon Medical (United States), ConMed (United States), Fujifilm (Japan), Cordis J&J (United States), Wilson (United States) and Alton (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Vacuum-assisted biopsy forceps offering minimal invasiveness and favorable reimbursement policies " is seen as one of major influencing trends for Biopsy Forceps Market during projected period 2023-2030.
The Biopsy Forceps market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Biopsy Forceps Market review Report?

Have a Query? Click Here

Other Related Reports

Hot and Cold Therapy Packs Comprehensive Study by Type (Cold Packs, Ice Packs, Hot Packs, Moist Therapy Packs, Others), Application (Arthritis, Chroinc Pain, Joint Contracture, Muscle Spasms, Others)...
$ 3350
Surgical Lights Comprehensive Study by Type (Surgical Lights {Ceiling Mounted, Mobile Surgical Lights, Surgical Headlights, Wall Mounted Surgical Lights}, Examination Lights {General Exam Light, Endo...
$ 3750
Radiation Therapy Equipment Comprehensive Study by Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy), Application (Skin and Lip Cancer, Head and Neck Canc...
$ 3750
Hysteroscopy Instruments Comprehensive Study by Type (Hand-held Instruments {Forceps, Scissors, Dilators, Others}, Hysteroscopes {Rigid Hysteroscopes, and Flexible Hysteroscopes}, Resectoscopes {Unip...
$ 3750
Orthodontic Equipments Comprehensive Study by Application (Hospitals, Dental Clinics), Consumables (Anchorage Appliances {Buccal Tubes, Miniscrews, Bands}, Ligatures {Elastomeric, Wire}, Brackets {Ae...
$ 3750
Prostate Biopsy System Comprehensive Study by Type (3D Imaging, Navigation System), Application (Hospitals, Ambulatory Surgical Center (ASCs), Diagnostic Centers, Others), Prostate (Benign Prostatic ...
$ 3450